Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs

Although patient preferences have been studied broadly for marketed products or around the time of submission to authorities and launch, patient preference studies have rarely been used during the early drug development phases. In this paper, we formulate three hypotheses supporting the use of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Nigel S., Cave, Julie, Holtorf, Anke-Peggy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491461/
https://www.ncbi.nlm.nih.gov/pubmed/31069227
http://dx.doi.org/10.3389/fmed.2019.00082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491461/
https://www.ncbi.nlm.nih.gov/pubmed/31069227
http://dx.doi.org/10.3389/fmed.2019.00082

Ejemplares similares